The rapid IgM-IgG combined antibody test for Covid-19 is used to qualitatively detect IgG and IgM antibodies of the novel coronavirus in human serum, plasma or whole blood in vitro. These indicate that a person’s immune system has responded to infection with the Covid-19 virus.
The rapid test kit is easy to use and can enable more effective and efficient decentralized screening among suspected patients.
That leads to quick identification of cases, quick treatment for those people and immediate isolation to prevent spread. Early testing also helps to identify anyone who came into contact with infected people so they too can be quickly treated.